Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders

Stock Information for Vaxart Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Vaxart Inc.

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results
Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET
Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors
Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
Vaxart Provides Business Update and Reports Full Year 2025 Financial Results
Vaxart to Host Upcoming Conference Calls
Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.